Clinical manifestations are complex and often involve multi-systemic burdens. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical manifestations, imaging checks, laboratory tests and pathological activation.
The platform can help align national and international teams of authoritative experts to provide accurate diagnoses and treatment regimens. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult-to-treat genetic metabolic disorders have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, with timely adjustment according to disease changes.
Multidisciplinary collaboration (MDT) is particularly important for the integrated management of Wilson's liver neurotype. The platform serves a team of nationally and internationally authoritative experts in the field of genetic metabolism in China's international medical service system, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.